HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Activity and efficacy of vinflunine in metastatic carcinoma of the bladder after failure of adjuvant treatment: description of a clinical case].

Abstract
Vinflunine is the only drug tested in a phase III trial and, to date, approved for advanced or metastatic bladder cancer after failure of a prior platinum-containing regimen. We report a case of a man with metastatic bladder cancer treated with vinflunine after failure of an adjuvant chemotherapy with carboplatin and gemcitabine.
AuthorsFranco Morelli
JournalRecenti progressi in medicina (Recenti Prog Med) Vol. 106 Issue 6 Pg. e300-5 (Jun 2015) ISSN: 2038-1840 [Electronic] Italy
Vernacular TitleAttività ed efficacia di vinflunina nel carcinoma metastatico della vescica in progressione dopo un trattamento adiuvante: descrizione di un caso clinico.
PMID26076423 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • vinflunine
  • Vinblastine
Topics
  • Aged
  • Antineoplastic Agents, Phytogenic (therapeutic use)
  • Carcinoma, Transitional Cell (drug therapy, secondary, surgery)
  • Chemotherapy, Adjuvant
  • Cystectomy (methods)
  • Disease Progression
  • Humans
  • Male
  • Neoplasm Invasiveness
  • Urinary Bladder Neoplasms (drug therapy, pathology, surgery)
  • Vinblastine (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: